RECURRENT OR METASTATIC CERVICAL CANCER
Clinical trials for RECURRENT OR METASTATIC CERVICAL CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OR METASTATIC CERVICAL CANCER trials appear
Sign up with your email to follow new studies for RECURRENT OR METASTATIC CERVICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Two-Drug combo outsmart advanced cervical cancer?
Disease control Not yet recruitingThis study looks at how well a combination of two drugs, iparomlimab and tuvonralimab (called QL1706), works for people with recurrent or metastatic cervical cancer that has worsened after platinum-based chemotherapy. Researchers will compare outcomes of those receiving QL1706 to…
Matched conditions: RECURRENT OR METASTATIC CERVICAL CANCER
Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo targets advanced cervical cancer
Disease control Not yet recruitingThis study tests two experimental drugs, MRG003 and QL1706, together in people with cervical cancer that has returned or spread and no longer responds to standard chemotherapy. About 41 adults will receive the combination to see if it shrinks tumors. The goal is to control the di…
Matched conditions: RECURRENT OR METASTATIC CERVICAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC